Impact of hepatitis C virus infection on clinical features, quality of life and survival of patients with lymphoplasmacytoid lymphoma/immunocytoma

Annals of Oncology

Volumn 9, Issue 5, 1998, Pages 499-504

  Silvestri, F ^a,c   Barillari, G ^a,d   Fanin, R ^a   Salmaso, F ^a   Pipan, C ^b   Falasca, E ^b   Puglisi, F ^c   Mariuzzi, L ^c   Zaja, F ^a   Infanti, L ^a   Patriarca, F ^a   Candoni, A ^a   Rogato, A ^a   Di Loreto, C ^c   Botta, G A ^b   Baccarani, M ^a  

^a Division of Hematology   (Italy)

^b Institute of Microbiology   (Italy)

^c UNIVERSITY HOSPITAL OF UDINE   (Italy)

^d GENERAL HOSPITAL   (Italy)

Author keywords

Clinical features; HCV infection; Lymphoplasmacytoid lymphoma immunocytoma; Quality of life

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL FEATURE; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; IMMUNOCYTOMA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE;

EID: 7144235813     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008265804550     Document Type: Article

References (32)

1. Harris NL, Jaffe ES, Stein H et al. A Revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood. 1994; 84: 1361 92.
2. Lennert K, Tamm I and Wacker HH. Histopathology and immunocytochemistry of lymph node biopsies in chronic lymphocytic leukemia and immunocytoma. Leuk Lymph 1991; (Suppl 1): 157 60.
3. Sundeen JT, Longo DL, Jaffe ES. CD5 expression in B-cell small lymphocytic malignancies. Correlations with clinical presentation and sites of disease. Am J Surg Pathol 1992; 16: 130-7.
4. Zukerberg LR, Medeiros JL, Ferry JA, Harris NL. Diffuse lowgrade B-cell lymphomas. Four clinically distinct subtypes defined by a combination of morphologic and immunophenotypic features. Am J Clin Pathol 1993; 100: 373-85.
5. Ferri C, Greco F, Longobardo G et al. Association between hepatitis C virus in mixed cryoglobulinemia. Clin Exp Rheumatol 1991; 9: 621-8.
6. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992; 327: 1490-5.
7. Misiani R, Bellavita P, Fenili D et al. Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann Intern Med 1992; 117: 573 7.
8. Silvestri F, Baccarani M. Hepatits C virus related lymphomas. Br J Haematol 1997; 99: 475-80.
9. Ferri C, Monti M, La Civita L et al. Hepatitis C virus infection in non-Hodgkin's B-cell lymphoma complicating mixed cryoglobulinemia. Eur J Clin Invest 1994; 24: 781-4.
10. Ferri C, Caracciolo F, Zignego AL et al. Hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Br J Haematol 1994; 88: 392-4.
11. Cavanna L, Sbolli G, Tanzi E et al. High prevalence of antibodies to hepatitic C virus in patients with lymphoproliferative disorders. Haematologica 1995; 80: 486-7.
12. McColl MD , Campbell Tait R. Hepatitis C virus infection in patients with lymphoproliferative disorders. Br J Haematol 1996; 92: 766-73.
13. Luppi M, Ferrari MG, Bonaccorsi G et al. Hepatitis C virus infection in subsets of neoplastic lymphoproliferations not associated with cryoglobulinemia. Leukemia 1996; 10: 351-5.
14. Luppi M, Longo G, Ferrari MG et al. Additional neoplasms and HCV infection in low-grade lymphoma of MALT type. Br J Haematol 1996; 94: 373-5.
15. Mazzaro C, Zagonel V, Monfardini S et al. Hepatitis C virus and non-Hodgkin's lymphomas. Br J Haematol 1996; 94: 544-50.
16. Silvestri F, Pipan C, Barillari G et al. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Blood 1996; 87: 4296-301.
17. Silvestri F Barillari G, Fanin R et al. Risk of hepatitis C virus infection. Waldenström's macroglobulinemia, and monoclonal gammopathies. Blood 1996; 88: 1125-6.
18. Silvestri F, Barillari G, Fanin R et al. Hepatitis C virus infection (and additional neoplasm) among marginal zone lymphomas. Br J Haematol 1997; 96: 427 8.
19. Silvestri F, Barillari G, Fanin R et al. Hepatitis C virus infection among cryoglobulinemic and non-cryoglobulinemic B-cell Non-Hodgkin's lymphomas. Haematologica 1997; 82: 314-7.
20. Izumi T, Sasaki R, Miura Y, Okamoto H. B-cell malignancy and hepatitis C virus infection. Leuk Res 1996; 20: 445.
21. Izumi T, Sasaki R, Miura Y, Okamoto H. Primary hepatosplenic lymphoma: Association with hepatitis C virus infection. Blood 1996; 87: 5380 1.
22. Mangia A, Clemente R, Musto P et al. Hepatitis C virus infection and monoclonal gammopathies not associated with cryoglobulinemia. Leukemia 1996; 10: 1209-13.
23. Musto P, Dell'Olio M, Carotenuto M et al. Hepatitis C virus infection: a new bridge betwwen hematologists and gastroenterologists? Blood 1996; 88: 752-3.
24. Mussini C, Ghini M, Mascia MT et al. Monoclonal gammopathies and hepatitis C virus infection. Blood 1995; 85: 1144-5.
25. Pioltelli P, Zehender G, Monti G et al. HCV and non-Hodgkin lymphoma. Lancet 1996; 347: 624-5.
26. Santini GF, Crovatto M, Modolo ML et al. Waldenström macroglobulinemia: A role of HCV infection? Blood 1993; 82: 2932.
27. Silvestri F, Barillari G, Fanin R et al. The genotype of the hepatitis C virus in patients with HCV-related B-cell non-Hodgkin's lymphoma. Leukemia 1997; 11: 2157-61.
28. Simmonds P, Holmes EC, Cha TA et al. Classification of hepatitis C virus into six maior genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Genet Virol 1993; 74: 2391-9.
29. Stuyer L, Wyseur A, van Arnhem W et al. Second-generation line probe assay for hepatitis C virus genotyping. J Clin Microbiol 1996; 34: 2259-66.
30. Tsubota A, Chayama K, Ikeda K et al. Factors predictive of response to interferon-a therapy in hepatitis C virus infection. Hepatology 1994; 19: 1088-94.
31. Mazzaro C, Franzin F, Tulissi P et al. Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to a-interferon therapy. Cancer 1996; 77: 2604-13.
32. Zaja F, Silvestri F, Russo D. Fludarabine in the treatment of essential mixed cryoglobulinaemia. Eur J Haematol 1996; 57: 259-60.